Meningioma
Symptoms, Doctors, Treatments, Advances & More

Meningioma Overview

Save information for later
Sign Up

Learn About Meningioma

View Main Condition: Brain Tumor

What is the definition of Meningioma?
Meningiomas are tumors that originate in the meninges, the membranes that surround the brain and spinal cord. Most Meningiomas are not cancerous (benign), though a minority of Meningiomas can be classified as atypical or cancerous (malignant). Though rare, malignant Meningiomas can be highly aggressive. However, even benign Meningiomas can cause problems if their growth affects neighboring areas of the brain. Though most Meningiomas grow slowly, there is no way to predict the rate of growth for a particular Meningioma or to know how long a specific Meningioma was growing before it was diagnosed. Signs and symptoms can vary but may include seizures, headaches, weakness in the arms and legs, and vision loss. Sometimes memory loss, carelessness, and unsteadiness are the only symptoms.
What are the alternative names for Meningioma?
  • Meningioma
Who are the top Meningioma Local Doctors?
Elite in Meningioma
Dr. Ricardo J. Komotar
Oncology | Neurosurgery
Elite in Meningioma
Dr. Ricardo J. Komotar
Oncology | Neurosurgery
Referral may be required
1295 Northwest 14th Street, 
Miami, FL 
305-243-6946
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ricardo Komotar is an Oncologist and a Neurosurgery provider practicing medicine in Miami, Florida. Dr. Komotar is rated as an Elite provider by MediFind in the treatment of Meningioma. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Meningioma, Glioblastoma, Awake Craniotomy, and Posterior Fossa Decompression. Dr. Komotar is currently accepting new patients.

Elite in Meningioma
Elite in Meningioma
Referral may be required

Duke Cancer Center Brain Tumor Clinic

20 Duke Medicine Cir, 
Durham, NC 
919-684-5301
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Allan Friedman is a Neurosurgery provider practicing medicine in Durham, North Carolina. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Meningioma. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, Awake Craniotomy, and Laminectomy. Dr. Friedman is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Friedman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Meningioma
Elite in Meningioma
Referral may be required

Northwell Health Ambulatory Surgery At The Center For Advanced Medicine

450 Lakeville Road, Entrance F, 
Lake Success, NY 
516-941-1260
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Schulder is a Neurosurgery provider practicing medicine in Lake Success, New York. Dr. Schulder is rated as an Elite provider by MediFind in the treatment of Meningioma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Schulder is board certified in American Board Of Neurological Surgery. Dr. Schulder is currently accepting new patients.

View All Doctors
What are the latest Meningioma Clinical Trials?
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions: Avoidance of Eloquent White Matter and Hippocampal Regions
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions: Avoidance of Eloquent White Matter and Hippocampal Regions
Who is this study for: Adult patients with Brain Cancer
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Radiation
Study Phase: Phase 2

Summary: In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS for intracranial lesions, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma
MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Other, Drug
Study Phase: Phase 2

Summary: This is an open-label, multicenter, randomized, phase 2 clinical study to evaluate the efficacy of \[177Lu\]Lu-DOTATATE in patients with progressive grade 1-3 intracranial meningioma.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 11, 2022
Published By: Genetic and Rare Diseases Informnation Center